Prevention and early detection of vascular complications of diabetes

被引：162

作者：

Marshall, Sally M. ^{[1
]}

Flyvbjerg, Allan

机构：

[1] Newcastle Univ, Sch Med, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Aarhus Univ, DK-8000 Aarhus, Denmark

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 333卷 / 7566期

关键词：

D O I：

10.1136/bmj.38922.650521.80

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：475 / 480

页数：14

共 65 条

[1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].

Adler, AI ;

Stratton, IM ;

Neil, HAW ;

Yudkin, JS ;

Matthews, DR ;

Cull, CA ;

Wright, AD ;

Turner, RC ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419

[2]

AGINS E, 2006, DIABETIC MED, V23, P331

[3] Factors affecting the quality of diabetes care in primary health care centres in Tunis [J].

Alberti, H ;

Boudriga, N ;

Nabli, M .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (03) :237-243

[4]

*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981

[5] The global burden of diabetic foot disease [J].

Boulton, AJM ;

Vileikyte, L ;

Ragnarson-Tennvall, G ;

Apelqvist, J .

LANCET, 2005, 366 (9498) :1719-1724

[6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[7] The pathobiology of diabetic complications - A unifying mechanism [J].

Brownlee, M .

DIABETES, 2005, 54 (06) :1615-1625

[8] Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis [J].

Casas, JP ;

Chua, WL ;

Loukogeorgakis, S ;

Vallance, P ;

Smeeth, L ;

Hingorani, AD ;

MacAllister, RJ .

LANCET, 2005, 366 (9502) :2026-2033

[9] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].

Chaturvedi, N .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379

[10] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

← 1 2 3 4 5 6 7 →